Effects of mibefradil and nifedipine on arteriolar myogenic responsiveness and intracellular Ca2+
- 1 November 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 131 (6) , 1065-1072
- https://doi.org/10.1038/sj.bjp.0703650
Abstract
1. Ca(2+) entry mechanisms underlying spontaneous arteriolar tone and acute myogenic reactivity remain uncertain. These studies aimed to compare the effects of nifedipine and the putative T-channel blocker, mibefradil, on arteriolar myogenic responsiveness and intracellular Ca(2+) (Ca(2+)(i)). 2. First order cremaster muscle arterioles (1A) were isolated from rats, cannulated, pressurized to 70 mmHg in the absence of intraluminal flow, and mechanical responses studied by video microscopy. The Ca(2+)(i) was measured using fluorescence imaging of Fura 2 loaded arterioles. 3. Both nifedipine and mibefradil showed dose-dependent inhibition of spontaneous myogenic tone (at 70 mmHg; pEC(50) 7.04+/-0.17 vs 6.65+/-0.20 respectively, n=6 for both, n.s.) and KCl-induced vasoconstriction (at 70 mmHg; pEC(50) 6.93+/-0. 38 vs 6.45+/-0.27 respectively, n=6 for both, n.s.). 4. In arterioles maintained at 50 mmHg, nifedipine (10(-7) and 10(-5) M) caused a concentration dependent reduction in Ca(2+)(i), however, mibefradil (10(-7) and 10(-5) M) had no effect. Furthermore nifedipine significantly attenuated the increase in Ca(2+)(i) associated with an acute pressure step (50 - 120 mmHg) whereas mibefradil was considerably less effective. 5. Mibefradil (10(-7) M) significantly attenuated contractile responses to 60 mM KCl without altering the KCl-induced increase in Ca(2+)(i), in contrast to nifedipine (10(-7) M) which reduced both Ca(2+)(i) and contraction. 6. Membrane potential of arterioles with spontaneous myogenic tone (70 mmHg) was -41.5+/-1. 0 mV. Nifedipine (10(-7) or 10(-5) M) had no effect on membrane potential, however mibefradil (10(-5) M) caused significant depolarization. 7. In summary, both mibefradil and nifedipine inhibit arteriolar spontaneous tone and acute myogenic reactivity. While there may be overlap in the mechanisms by which these agents inhibit tone, differences in effects on membrane potential and intracellular Ca(2+) levels suggest mibefradil exhibits actions other than blockade of Ca(2+) entry in skeletal muscle arterioles.Keywords
This publication has 37 references indexed in Scilit:
- Metabolic interactions between mibefradil and HMG‐CoA reductase inhibitors: an in vitro investigation with human liver preparationsBritish Journal of Clinical Pharmacology, 1999
- Human vascular to cardiac tissue selectivity of L‐ and T‐type calcium channel antagonistsBritish Journal of Pharmacology, 1998
- Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressureThe Journal of Physiology, 1998
- Inhibition by mibefradil, a novel calcium channel antagonist, of Ca2+‐ and volume‐activated Cl− channels in macrovascular endothelial cellsBritish Journal of Pharmacology, 1997
- Protein Kinase C Mechanism Enhances Vascular Muscle Relaxation by the Ca2+ Antagonist, Ro 40-5967Journal of Vascular Research, 1996
- Arteriolar arcades and pressure distribution in cremaster muscle microcirculationMicrovascular Research, 1992
- Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation.Circulation Research, 1991
- Classes of Calcium Channels in Vertebrate CellsAnnual Review of Physiology, 1989
- Pressure-dependent membrane depolarization in cat middle cerebral artery.Circulation Research, 1984